Cronos Inc logo

CRON - Cronos Inc Share Price

$5.79 0.2  4.3%

Last Trade - 12/08/20

Mid Cap
Market Cap £1.49bn
Enterprise Value £476.6m
Revenue £24.1m
Position in Universe 1825th / 6376
Unlock CRON Revenue
Relative Strength (%)
1m -17.5%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -59.5%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.42 3.15 12.1 23.8 42.7 97.8
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Cronos Group Inc revenues increased 72% to $18.3M. Net loss totaled $30.9M vs. income of $500.1M. Revenues reflect Cannabis Extracts segment increase from $2.7M to $9.7M, Other segment increase from $98K to $233K. Net loss reflects Gain on revaluation of derivative liabil decrease of 85% to $77.5M (income), Sales and marketing increase from $5.1M to $13.6M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


CRON Revenue Unlock CRON Revenue

Net Income

CRON Net Income Unlock CRON Revenue

Normalised EPS

CRON Normalised EPS Unlock CRON Revenue

PE Ratio Range

CRON PE Ratio Range Unlock CRON Revenue

Dividend Yield Range

CRON Dividend Yield Range Unlock CRON Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CRON EPS Forecasts Unlock CRON Revenue
Profile Summary

Cronos Group Inc is a cannabinoid company. The Company is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivations Ltd, Cronos Israel G.S. Manufacturing Ltd, Cronos Israel G.S. Store Ltd and Cronos Israel G.S. Pharmacies Ltd.

Last Annual December 31st, 2019
Last Interim June 30th, 2020
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Index Nasdaq Composite ,
Exchange NASDAQ Global Market (Dual Listing)
Shares in Issue 349,886,402
Free Float (0.0%)
Eligible for
CRON Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CRON
Upcoming Events for CRON
Frequently Asked Questions for Cronos Inc
What is the Cronos Inc share price?

As of 12/08/20, shares in Cronos Inc are trading at $5.79, giving the company a market capitalisation of £1.49bn. This share price information is delayed by 15 minutes.

How has the Cronos Inc share price performed this year?

Shares in Cronos Inc are currently trading at $5.79 and the price has moved by -58.11% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cronos Inc price has moved by -63.52% over the past year.

What are the analyst and broker recommendations for Cronos Inc?

There are no analysts currently covering Cronos Inc.

When will Cronos Inc next release its financial results?

Cronos Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Cronos Inc dividend yield?

Cronos Inc does not currently pay a dividend.

Does Cronos Inc pay a dividend?

Cronos Inc does not currently pay a dividend.

When does Cronos Inc next pay dividends?

Cronos Inc does not currently pay a dividend.

How do I buy Cronos Inc shares?

To buy shares in Cronos Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cronos Inc?

Shares in Cronos Inc are currently trading at $5.79, giving the company a market capitalisation of £1.49bn.

Where are Cronos Inc shares listed? Where are Cronos Inc shares listed?

Here are the trading details for Cronos Inc:

Country of listing: United States
Exchange: NMQ
Ticker Symbol: CRON
What kind of share is Cronos Inc?

Based on an overall assessment of its quality, value and momentum, Cronos Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Cronos Inc share price forecast 2020?

Shares in Cronos Inc are currently priced at $5.79. At that level they are trading at 12.35% premium to the analyst consensus target price of 0.00.

Analysts covering Cronos Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.1214548872 for the next financial year.

How can I tell whether the Cronos Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cronos Inc. Over the past six months, the relative strength of its shares against the market has been -18.74%. At the current price of $5.79, shares in Cronos Inc are trading at -15.87% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cronos Inc PE Ratio?

The Cronos Inc PE ratio based on its reported earnings over the past 12 months is 8.91. The shares are currently trading at $5.79.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Cronos Inc?

Cronos Inc's management team is headed by:

Michael Gorenstein - CHM
Jason Adler - IND
William Hilson - OTH
James Rudyk - LED
Jerry Barbato - CFO
Kevin Crosthwaite - DRC
Murray Garnick - DRC
Bruce Gates - DRC
Jeffrey Jacobson - GMG
David Hsu - COO
Xiuming Shum - EVP
Todd Abraham - OTH
Jody Begley - DRC
Heather Newman - DRC
Robert Rosenheck - CEX
Anna Shlimak - SVP
Who are the major shareholders of Cronos Inc?

Here are the top five shareholders of Cronos Inc based on the size of their shareholding:

Altria Group Inc Holding Company
Percentage owned: 44.75% (156.6m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 2.89% (10.1m shares)
Adler (Jason Marc) Individual Investor
Percentage owned: 2.63% (9.20m shares)
Chescapmanager, L.L.C. Investment Advisor
Percentage owned: 2.54% (8.87m shares)
ETFMG Alternative Harvest ETF Mutual Fund
Percentage owned: 2.31% (8.10m shares)
Similar to CRON
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.